RACHEL TALBOT: Open Payments
NPI 1972961472 · CHARLOTTESVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$740 in 32 payments from 9 companies in 2025. Trend: 2023 $632 · 2024 $360 · 2025 $740
Food & beverage: $740
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $242 |
| Arcutis Biotherapeutics, Inc. | 4 | $135 |
| UCB, Inc. | 3 | $105 |
| ABBVIE INC. | 3 | $67 |
| GENZYME CORPORATION | 2 | $65 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| Incyte Corporation | 1 | $29 |
| Galderma Laboratories, L.P. | 1 | $21 |
Products named: TREMFYA, Zoryve, Bimzelx, DUPIXENT, RINVOQ, OPZELURA, COSENTYX, NEMLUVIO.
Industry payments across VA — which companies pay providers there.
